Literature DB >> 23416076

WITHDRAWN: Clearance of lysosomal glycogen accumulation by Transcription factor EB (TFEB) in muscle cells from lysosomal alpha-glucosidase deficient mice.

Hoi Ming Li1, Erin Feeney, Lishu Li, Hossein Zare, Rosa Puertollano, Nina Raben.   

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy. Published by Elsevier Inc.

Entities:  

Year:  2013        PMID： 23416076      PMCID： PMC3687018          DOI： 10.1016/j.bbrc.2013.02.026

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  37 in total

1.  Monitoring autophagy in lysosomal storage disorders.

Authors:  Nina Raben; Lauren Shea; Victoria Hill; Paul Plotz
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

2.  Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification.

Authors:  Hsiang-Po Huang; Pin-Hsun Chen; Wuh-Liang Hwu; Ching-Yu Chuang; Yin-Hsiu Chien; Lee Stone; Chung-Liang Chien; Li-Tzu Li; Shu-Chuan Chiang; Hsin-Fu Chen; Hong-Nerng Ho; Chung-Hsuan Chen; Hung-Chih Kuo
Journal:  Hum Mol Genet       Date:  2011-09-15       Impact factor: 6.150

3.  Culturing satellite cells from living single muscle fiber explants.

Authors:  J D Rosenblatt; A I Lunt; D J Parry; T A Partridge
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

4.  The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis.

Authors:  Agnes Roczniak-Ferguson; Constance S Petit; Florian Froehlich; Sharon Qian; Jennifer Ky; Brittany Angarola; Tobias C Walther; Shawn M Ferguson
Journal:  Sci Signal       Date:  2012-06-12       Impact factor: 8.192

5.  DNA transfection of mammalian skeletal muscles using in vivo electroporation.

Authors:  Marino DiFranco; Marbella Quinonez; Joana Capote; Julio Vergara
Journal:  J Vis Exp       Date:  2009-10-19       Impact factor: 1.355

Review 6.  Pompe's disease.

Authors:  Ans T van der Ploeg; Arnold J J Reuser
Journal:  Lancet       Date:  2008-10-11       Impact factor: 79.321

7.  Murine muscle cell models for Pompe disease and their use in studying therapeutic approaches.

Authors:  Shoichi Takikita; Rachel Myerowitz; Kristien Zaal; Nina Raben; Paul H Plotz
Journal:  Mol Genet Metab       Date:  2009-01-22       Impact factor: 4.797

8.  The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease.

Authors:  Suhrad G Banugaria; Sean N Prater; Yiu-Ki Ng; Joyce A Kobori; Richard S Finkel; Roger L Ladda; Yuan-Tsong Chen; Amy S Rosenberg; Priya S Kishnani
Journal:  Genet Med       Date:  2011-08       Impact factor: 8.822

9.  Transcriptional activation of lysosomal exocytosis promotes cellular clearance.

Authors:  Diego L Medina; Alessandro Fraldi; Valentina Bouche; Fabio Annunziata; Gelsomina Mansueto; Carmine Spampanato; Claudia Puri; Antonella Pignata; Jose A Martina; Marco Sardiello; Michela Palmieri; Roman Polishchuk; Rosa Puertollano; Andrea Ballabio
Journal:  Dev Cell       Date:  2011-09-01       Impact factor: 12.270

10.  A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.

Authors:  Carmine Settembre; Roberto Zoncu; Diego L Medina; Francesco Vetrini; Serkan Erdin; SerpilUckac Erdin; Tuong Huynh; Mathieu Ferron; Gerard Karsenty; Michel C Vellard; Valeria Facchinetti; David M Sabatini; Andrea Ballabio
Journal:  EMBO J       Date:  2012-02-17       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.